Quarterly report · Q3
9158.TEDINET S100STWG
Period2023-04-01 → 2023-12-31
Filed2024-02-09
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.4bn | 2023-04-01 → 2023-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥8.0bn | 2023-10-01 → 2023-12-31d | Cons. | Revenue IFRS |
| Revenue | ¥35.2bn | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥27.4bn | 2022-04-01 → 2022-12-31 | Cons. | Revenue IFRS |
| Revenue | ¥8.8bn | 2022-10-01 → 2022-12-31d | Cons. | Revenue IFRS |
| Operating income | ¥2.6bn | 2023-04-01 → 2023-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥842m | 2023-10-01 → 2023-12-31d | Cons. | Operating profit loss IFRS |
| Operating income | ¥3.2bn | 2022-04-01 → 2022-12-31 | Cons. | Operating profit loss IFRS |
| Operating income | ¥863m | 2022-10-01 → 2022-12-31d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥2.4bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥751m | 2023-10-01 → 2023-12-31d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥3.6bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥3.1bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥857m | 2022-10-01 → 2022-12-31d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥1.5bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥461m | 2023-10-01 → 2023-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥2.1bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥634m | 2022-10-01 → 2022-12-31d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥1.5bn | 2023-04-01 → 2023-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥459m | 2023-10-01 → 2023-12-31d | Cons. | Profit loss IFRS |
| Net income | ¥2.1bn | 2022-04-01 → 2022-12-31 | Cons. | Profit loss IFRS |
| Net income | ¥630m | 2022-10-01 → 2022-12-31d | Cons. | Profit loss IFRS |
| Total assets | ¥58.0bn | at 2023-12-31 | Cons. | Assets IFRS |
| Total assets | ¥39.8bn | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥37.5bn | at 2022-12-31 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥31.7bn | at 2023-12-31 | Cons. | Liabilities IFRS |
| Total liabilities | ¥27.8bn | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥26.3bn | at 2023-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥11.9bn | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥11.5bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥9.7bn | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥26.1bn | at 2023-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥11.7bn | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥11.3bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥17.5bn | at 2023-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥4.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥4.5bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥4.4bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥2.5bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | −¥408m | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥4.3bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥6.7bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥2.6bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥15.2bn | 2023-04-01 → 2023-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | ¥4.0bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥3.0bn | 2022-04-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥55.45 | 2023-04-01 → 2023-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥15.73 | 2023-10-01 → 2023-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥113.9 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥101.86 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥29.6 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥55.45 | 2023-04-01 → 2023-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥15.73 | 2023-10-01 → 2023-12-31d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥113.9 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥101.86 | 2022-04-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥29.6 | 2022-10-01 → 2022-12-31d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 44.9% | at 2023-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 29.4% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 30.2% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 98
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-12-31 | ¥148m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-10-01 → 2023-12-31 | ¥50m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-12-31 | ¥148m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-10-01 → 2023-12-31 | ¥50m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-12-31 | ¥13m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-10-01 → 2023-12-31 | ¥9m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-12-31 | −¥477m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2023-12-31 | −¥188m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-12-31 | −¥477m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2023-12-31 | −¥188m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-12-31 | −¥874m |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2023-12-31 | −¥298m |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥7.5bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥7.5bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥0 |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥0 |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥142m |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥205m |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥8.3bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥8.3bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥497m |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥111m |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue | 2023-04-01 → 2023-12-31 | ¥8.0bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue | 2023-10-01 → 2023-12-31 | ¥2.7bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue external | 2023-04-01 → 2023-12-31 | ¥7.5bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue external | 2023-10-01 → 2023-12-31 | ¥2.5bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥477m |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥187m |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | segment profit | 2023-04-01 → 2023-12-31 | ¥2.8bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | segment profit | 2023-10-01 → 2023-12-31 | ¥815m |
| —segment total | revenue | 2023-04-01 → 2023-12-31 | ¥23.7bn |
| —segment total | revenue | 2023-10-01 → 2023-12-31 | ¥8.2bn |
| —segment total | revenue external | 2023-04-01 → 2023-12-31 | ¥23.2bn |
| —segment total | revenue external | 2023-10-01 → 2023-12-31 | ¥8.0bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥477m |
| —segment total | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥188m |
| —segment total | segment profit | 2023-04-01 → 2023-12-31 | ¥3.5bn |
| —segment total | segment profit | 2023-10-01 → 2023-12-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-12-31 | ¥23.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2023-12-31 | ¥8.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-12-31 | ¥23.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2023-12-31 | ¥8.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-12-31 | ¥477m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2023-12-31 | ¥188m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-12-31 | ¥3.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2023-12-31 | ¥1.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-12-31 | ¥147m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-10-01 → 2022-12-31 | ¥48m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥147m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-10-01 → 2022-12-31 | ¥48m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥18m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-10-01 → 2022-12-31 | ¥10m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥178m |
| Reconciling Itemsreconciling | revenue | 2022-10-01 → 2022-12-31 | −¥70m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥178m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-10-01 → 2022-12-31 | −¥70m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥604m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2022-12-31 | −¥218m |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥1.6bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥4.6bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥1.6bn |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥253m |
| jpcrp040300-q3r_E37214-000Hospicereportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥57m |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥9.3bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥2.8bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥9.3bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥2.8bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥1.1bn |
| jpcrp040300-q3r_E37214-000In Home Nursingreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥264m |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥13.6bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue | 2022-10-01 → 2022-12-31 | ¥4.3bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥13.4bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue external | 2022-10-01 → 2022-12-31 | ¥4.2bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥178m |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥70m |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥2.4bn |
| jpcrp040300-q3r_E37214-000Management Supportreportable segment | segment profit | 2022-10-01 → 2022-12-31 | ¥749m |
| —segment total | revenue | 2022-04-01 → 2022-12-31 | ¥27.5bn |
| —segment total | revenue | 2022-10-01 → 2022-12-31 | ¥8.8bn |
| —segment total | revenue external | 2022-04-01 → 2022-12-31 | ¥27.3bn |
| —segment total | revenue external | 2022-10-01 → 2022-12-31 | ¥8.7bn |
| —segment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥178m |
| —segment total | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥70m |
| —segment total | segment profit | 2022-04-01 → 2022-12-31 | ¥3.8bn |
| —segment total | segment profit | 2022-10-01 → 2022-12-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥27.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2022-12-31 | ¥8.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥27.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2022-12-31 | ¥8.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥178m |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-10-01 → 2022-12-31 | ¥70m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥3.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2022-12-31 | ¥1.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 945
| Item | Context | Value | Unit |
|---|---|---|---|
| Proceeds from issuance of shares fin cf IFRS | Prior1YTDDuration | － | JPY |
| Proceeds from issuance of shares fin cf IFRS | CurrentYTDDuration | 13109000000 | JPY |
| Other fin cf IFRS | Prior1YTDDuration | － | JPY |
| Other fin cf IFRS | CurrentYTDDuration | -0 | JPY |
| Net cash provided by used in financing activities IFRS | Prior1YTDDuration | 2974000000 | JPY |
| Net cash provided by used in financing activities IFRS | CurrentYTDDuration | 15175000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | Prior1YTDDuration | 145000000 | JPY |
| Effect of exchange rate changes on cash and cash equivalents IFRS | CurrentYTDDuration | -37000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | Prior1YTDDuration | 116000000 | JPY |
| Net increase decrease in cash and cash equivalents IFRS | CurrentYTDDuration | 13412000000 | JPY |
| Cash and cash equivalents IFRS | Prior2YearInstant | 4355000000 | JPY |
| Cash and cash equivalents IFRS | Prior1YearInstant | 4120000000 | JPY |
| Cash and cash equivalents IFRS | Prior1QuarterInstant | 4471000000 | JPY |
| Cash and cash equivalents IFRS | CurrentQuarterInstant | 17532000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000ManagementSupportReportableSegmentMember | 13409000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000HospiceReportableSegmentMember | 4612000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000InHomeNursingReportableSegmentMember | 9277000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_ReportableSegmentsMember | 27298000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 147000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 27445000000 | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenue from external customers IFRS | Prior1YTDDuration | 27445000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000ManagementSupportReportableSegmentMember | 178000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000HospiceReportableSegmentMember | － | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000InHomeNursingReportableSegmentMember | － | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_ReportableSegmentsMember | 178000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | － | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 178000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration_ReconcilingItemsMember | -178000000 | JPY |
| Intersegment revenue IFRS | Prior1YTDDuration | － | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000ManagementSupportReportableSegmentMember | 13587000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000HospiceReportableSegmentMember | 4612000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000InHomeNursingReportableSegmentMember | 9277000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_ReportableSegmentsMember | 27476000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 147000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 27623000000 | JPY |
| Revenue IFRS | Prior1YTDDuration_ReconcilingItemsMember | -178000000 | JPY |
| Revenue IFRS | Prior1YTDDuration | 27445000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000ManagementSupportReportableSegmentMember | 2404000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000HospiceReportableSegmentMember | 253000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000InHomeNursingReportableSegmentMember | 1096000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_ReportableSegmentsMember | 3753000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 18000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 3771000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration_ReconcilingItemsMember | -604000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration | 3166000000 | JPY |
| Finance income IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000ManagementSupportReportableSegmentMember | － | JPY |
| Finance income IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000HospiceReportableSegmentMember | － | JPY |
| Finance income IFRS | Prior1YTDDuration_jpcrp040300-q3r_E37214-000InHomeNursingReportableSegmentMember | － | JPY |
| Finance income IFRS | Prior1YTDDuration_ReportableSegmentsMember | － | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |